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article under the CC BY-NC-ND licenseAbstract The purpose of the present study was to provide the first evidence of the poten-
tial function of the polyherbal combination of soybeans, brown rice, and coconut water
(EMSA eritin), as it has been suggested as a therapeutic agent because it, at least in part,
increases the production of functional hematopoietic stem cells after irradiation. The study
was conducted with 24 male mice (Mus musculus), which were divided into six groups con-
sisting of four mice each. This study used three EMSA eritin doses: 1.04 mg/kg body weight
(B.W.), 3.125 mg/kg B.W., and 9.375 mg/kg B.W. All treatment groups, except for normal
controls, were exposed to sublethal doses of irradiation and then given EMSA eritin therapy
for 15 days. Growth and differentiation of CD4 and CD8 T-lymphocytes in the thymus and the
number of stromal cell-derived factor 1 (SDF1)-expressing cells in the spleen, bone marrow,
and liver were analyzed using flow cytometry. Results showed that administration of EMSA
eritin was capable of significantly inducing lymphocytic proliferation and differentiation
and increased the number of SDF1-expressing cells in the spleen, bone marrow, and liver.
SDF1 is a chemokine essential to lymphocyte migration and hematopoietic cell development;Sciences Doctoral Study Program, Faculty of Medicine, Brawijaya University, Jl. Veteran, Malang,
oo.com (M. Ibrahim).
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148 M. Ibrahim et al.thus, it can be concluded that EMSA eritin is a good candidate as a therapeutic agent to
restore the number of hematopoietic cells after irradiation.
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Chemokines are molecules that control the direction of
leukocyte movement to the site in which they are pro-
duced. Stromal cell-derived factor 1 (SDF1) belongs to the
group of a-chemokines that bind to the transmembrane
protein receptor CXCR4. Although SDF1 is a member of the
CXC chemokines, SDF1 has some unique characters. Firstly,
the locus of the SDF1 gene in mice (6F1) and humans
(10q11.1) is a gene locus of conserved homology, while the
locus of other CXC chemokines in humans is 4q12-21.1,2
Secondly, SDF1 is continuously produced in a variety of
organs, including hematopoietic organs and lymphoid,3
whereas other chemokines are produced only temporarily
when they are inflammation-induced. Thirdly, SDF1 is
highly conserved; in mice and humans the mature SDF1
protein has a homology of >95%.1 Fourthly, a damaged SDF1
gene in mice is lethal.4
One of the main physiological functions of SDF1/CXCR4
is to regulate homing and self-defense of stem cells and
hematopoietic progenitor cells.5 SDF1 also serves to in-
crease the proliferation of normal hematopoietic progeni-
tor cells and regulate cell B growth. Interaction of SDF1 and
its receptor CXCR4 is believed to play an important role in
various processes, such as, SDF1 is capable of attracting
CXCR4-expressing progenitor cells to the bone marrow
microenvironment, whereas damaged interaction of SDF1/
CXCR4 in the bone marrow can facilitate cellular movement
to the peripheral circulation.6
Radiotherapy constitutes an important method in tumor
therapy. It is aimed at killing cancer cells without damaging
the integrity of healthy tissues and cells. Exposure to
ionizing radiation and chemotherapy not only causes dam-
age to the bone marrow but, in the long term, will lead to
damage to the hematopoietic system. The damage is to the
mechanism of hematopoietic stem cell (HSC) renewal,
causing the loss of HSC self-renewal.7 In hematopoietic
cells the primary response to irradiation is induction of the
cells to undergo apoptosis, whereas in the tumor tissue,
fibroblast and epithelial cells primary response to irradia-
tion is thought to be the induction of stress-induced pre-
mature senescence.8 g-ray irradiation induces apoptosis
through the intrinsic mechanism due to DNA damage.9
Potential of the polyherbal combination of soybeans,
brown rice, and coconut water to repair damaged HSCs
from irradiation has not been investigated. Genistein in
soybeans serves as a protective agent against g-ray irradi-
ation involved in the process of stimulation of hematopoi-
etic recovery. The role of genistein is related to its ability
to improve HSC regeneration and proliferation.10 One of the
antioxidant activities of pigmented rice is to scavenge free
radicals due to radiation exposure.11 Coconut water con-
tains cytokinins consisting of kinetin and riboside,12 inwhich kinetin is known to retard endothelial cells’ senes-
cence by increasing the capacity of cell proliferation and
cell metabolism.13 The purpose of the present study was to
determine the effects of combined polyherbal extracts of
soybeans, brown rice, and coconut water (EMSA eritin) on
the expression of the chemokine SDF1 and its relation to
lymphocytic development and differentiation.
Material and Methods
Preparation of polyherbal extracts
Cleanly washed soybeans and brown rice were dried in a
vacuum oven at 40C. Then, materials were mashed using a
60-mesh communiting mill. Extraction was carried out for 2
hours at 50C using water as the solvent at a ratio of ma-
terials and water of 1:10. Extracts were then evaporated
using a freezer dryer for 24 hours at 60C. Extracts of co-
conut water were prepared by filtering coconut water using
a separator and then evaporated to form a dry powder. The
drying process was performed by using a freezer dryer.
Methods of radiation exposure and EMSA therapy
This study used mice (Mus musculus) with replication
involving four mice for each group. EMSA eritin and eryth-
ropoietin (EPO) were administered for 15 days after the
experimental animals have been exposed to radiation.
There were six treatment groups: (1) normal group; (2)
negative control group (exposed to radiation); (3) positive
control group (exposed to radiation and treated with EPO);
(4) treatment group 1 [exposed to radiation and given EMSA
eritin therapy at Dose 1 of 1.04 mg/kg body weight (B.W.)];
(5) treatment group 2 (exposed to radiation and given EMSA
eritin therapy at Dose 2 of 3.125 mg/kg B.W.); and (6)
treatment group 3 (exposed to radiation and given EMSA
eritin therapy at Dose 3 of 9.375 mg/kg B.W.). Radiation
exposure was performed in the Radiology Laboratory of
Saiful Anwar General Hospital, Malang, Indonesia. Total
body irradiation was exposed at a sublethal dose (6 Gy/
600 rad) using the Exposure Instrument Gammacell-40 137
Ce irradiator (Atomic Energy of Canada Ltd., Ontario,
Canada) at a dose rate of 0.76 Gy/min.
Isolation of lymphocytes
Mice were killed by cervical dislocation. Lymphocytes were
isolated from the spleen, thymus, and bone marrow. Organs
taken were washed with phosphate-buffered saline (PBS)
and then placed on a sterilized membrane wire. Subse-
quently, organs were squeezed clockwise to remove the
lymphocytes out of the organs. The suspension was then
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10 minutes at 4C. The pellets were subsequently resus-
pended with cold PBS. In order to isolate the lymphocytes
cells from suspension, erythrocytes were lysed using NH4Cl
and followed by incubation using rat antimouse CD16/CD32
to block the nonspecific Fc receptor binding. Monoclonal
antibodies, rat antimouse CD4 and CD8, were used for se-
lection. Then the suspension was analyzed using flow
cytometry (data not shown).
Flow cytometry
SDF1 expression on the surface of lymphocytes and he-
patocytes was analyzed using flow cytometry. Directly
labeled monoclonal antibody was used to bind to the
target antigens (SDF1, CD4, and CD8). Immunofluores-
cence staining was performed by incubating the cells on
ice for 30 minutes with the primary antibody and then
washing them twice with ice-cold PBS and 0.1% bovine
serum albumin. Subsequently, the cells were labeled with
isotype-matched second-stage fluorescein isothiocyanate-
conjugated goat antimouse immunoglobulin-G for 30 mi-
nutes at 4C. The percentage of stained cells was evalu-
ated by comparison with the isotype control. Analyses
were performed using a FACScan flow cytometer (Becton
Dickinson and Company, New Jersey, NJ, USA) and dead
cells were excluded from the analysis using forward
scatter and side scatter. Analyses were performed for at
least 10,000 events and data were analyzed using PC-lysis
research software (Becton Dickinson).
Statistics analysis
Results are presented as means  standard deviation.
CellQuest software (Becton Dickinson and Company, New
Jersey, USA) and one-way analysis of variance (ANOVA)
were used to analyze the differences among each treat-
ment group and control group (p < 0.05).
Results
EMSA eritin increased migration of lymphocytes
through increased production of SDF1 in the spleen
Mice treated with EMSA eritin after being exposed to a
sublethal dose of irradiation (600 rad) increased production
of SDF1 in the spleen (Figure 1A). At least in part, from
Figure 1B, there was an increasing number of SDF1-
expressed cells in bone marrow after treatment and it has
been suggested that the increasing production of SDF1 were
followed by induced migration of lymphocytes. Adminis-
tration of EMSA eritin at all doses was capable of signifi-
cantly increasing the number of SDF1-expressing cells after
exposure to radiation. In the treatment group 3, the num-
ber of SDF1-expressing lymphocytes in the spleen was
significantly higher (20.78%) compared with the groups
treated with EMSA eritin at a lower dose (Dose 1, 4.45%;
Dose 2, 12.63%). The percentage of SDF1-expressing cells in
treatment groups 2 and 3 was found to be higher than in the
normal group (6.84%) and the positive control group treatedwith EPO (7.45%). This suggested that Doses 2 and 3 of EMSA
eritin in this study were optimal dosages in replacing the
function of EPO to increase SDF1 expression and lympho-
cyte migration.
EMSA eritin increased production of pre-B cell
growth-stimulating factor in bone marrow
compartments
Administration of EMSA eritin was capable of increasing
the number of SDF1-expressing cells in the mice’s bone
marrow after exposure to the sublethal dose of irradiation
(Figure 1C and D). ANOVA analysis (p < 0.05) showed that
administration of EPO and EMSA eritin at Dose 1 was
incapable of restoring the number of SDF1-expressing
cells up to that of the normal group. However, adminis-
tration of EMSA eritin at Doses 2 and 3 was found to
significantly increase the number of SDF1-expressing cells
to exceed that of the normal group. Dose 2 (9.09%) was
found to be capable of restoring the number of SDF1-
expressing cells to the level closest to that of the
normal group (7.49%) compared with Dose 1 (5.04%) and
Dose 3 (34.85%); however, Dose 3 was most capable of
increasing the number of SDF1-expressing cells compared
with that of other groups.
EMSA eritin increased expression of SDF1 in
hepatocytes
In addition to the spleen and bone marrow, administration
of EMSA eritin was capable of increasing SDF1-expressing
hepatocytes exposed to a sublethal dose of irradiation
(Figure 1E). This measurement was conducted to prove that
the effect of treatment to increase SDF1 production was
not the organ specific effects, but also in other organs in
which the SDF1 production cells could be found. Exposure
to radiation was capable of reducing the number of SDF1-
expressing hepatocytes up to 2.18%. Administration of
EMSA eritin at all doses was capable of increasing the
number of SDF1-expressing hepatocytes to exceed that of
the normal group. Dose 1 (3.61%) was found to be capable
of restoring the number of SDF1-expressing cells to the
level closest to that of the normal group (2.39%) compared
with Dose 2 (5.37%) and Dose 3 (7.32%).
EMSA eritin normalized development and
differentiation of T-cells in the thymus
Irradiation was capable of inhibiting the development of
both CD4 and CD8 T-cells. After exposure to radiation, T-
cells could not maturate quickly. T-cells would likely
remain on the status of pre-T cells (CD4þCD8þ). Results
showed that administration of EMSA eritin at various doses
to mice exposed to a sublethal dose of irradiation was
capable of promoting the pre-T cells to immediately
differentiate and maturate into both mature CD4 and CD8
T-cells (Figure 2). ANOVA showed that exposure to the
sublethal dose of irradiation was found to decrease the
number of CD4 and CD8 T-cells in the thymus, in which the
administration of EMSA eritin at Dose 2 (3.125 mg/g B.W.)
and Dose 3 (9.375 mg/g B.W.) was capable of significantly
Figure 1 EMSA eritin induces migration of lymphocytes by increasing: (A, B) stromal cell-derived factor 1 (SDF1) production in the
spleen; (C, D) spinal cord; and (E) the liver. Doses 1e3 of EMSA eritin are capable of significantly increasing the number of SDF1-
expressing cells in the spleen after irradiation, whereas only Doses 2 and 3 are capable of significantly increasing the number of
SDF1-expressing cells in the bone marrow (p < 0.05). EPOZ erythropoietin; RadZ radiation; SDF1Z stromal cell-derived factor 1;
SSC Z systemic sclerosis.
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normal group. Of the three doses of EMSA eritin adminis-
tered, Dose 3 (28.29%) was found to be most capable of
increasing the growth and differentiation of CD4 T-cells
compared with the other two doses; however, the dose
capable of restoring the growth and differentiation of CD4
T-cells to the number closest to that of the normal group
was Dose 2 (17.79%). With regard to the analysis of the
number of CD8 T-cells, it appeared that administration of
EMSA eritin at Doses 1 and 2 was capable of restoring the
number of CD8 T-cells to the level of the normal group
(2.28%), but Dose 3 was most capable of significantly
increasing the number of CD8 T-cells compared with that of
other groups (3.87%).
Discussion
SDF1 is a chemokine for homeostasis, in which is the main
function of homeostatic chemokines is to regulate thetrafficking of hematopoietic cells and to form secondary
lymphoid tissues. An increase in the number of cells
expressing SDF1 molecules on lymphocytes of the spleen
and bone marrow after administration of EMSA eritin indi-
cated that administration of the compound was capable of
improving irradiation-induced migration of lymphocytes.
SDF1 is found to attract stem cells and hematopoietic
progenitor cells that express CXCR4 to migrate to the bone
marrow microenvironment,14 while damaged interaction of
SDF1/CXCR4 in bone marrow may facilitate the cells’
movement towards peripheral blood circulation.6 SDF1
expression is crucial to provide directions to the cells during
the migration. A study by Ratajczak et al15 that knocked out
the SDF1 gene or CXCR4 gene in rats reported an impaired
hematopoiesis caused by damage to the trafficking of HSCs
from liver to the embryonic bone marrow. Abnormalities in
SDF1/CXCR4 signaling have also been reported to cause
damage to cardiac and brain development, as well as
impaired vascularization.15
Figure 2 EMSA eritin normalizes the development and differentiation of T-cells in the thymus after irradiation: (A) flow
cytometry dot plot demonstrating CD4 and CD8 cells in thymus; (B) the CD4 population of thymus in each experimental groups; and
(C) the CD8 population of thymus in each experimental groups. Administration of EMSA eritin at various doses to mice exposed to a
sublethal dose of irradiation was capable of promoting the pre-T cells to immediately differentiate and maturate into both mature
CD4 and CD8 T-cells. EPO Z erythropoietin; Rad Z radiation.
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increase the expression of the chemokine SDF1/CXCL12 and
increase the trafficking of stem cells in the bone
marrow.16e18 These results differ from those of the present
study that demonstrated that a sublethal dose of irradia-
tion (6 Gy) could significantly decrease SDF1 expression and
inhibit the growth and differentiation of T-lymphocytes.
Increased expression of SDF1 and maturation of T-lympho-
cyte occurred only after the experimental animals have
been given EMSA eritin for 15 days subsequent to being
irradiated. The chemokine SDF1 has a complex role in
migration, proliferation, and differentiation of leuko-
cytes.6,19 Previous studies reported that impaired SDF1
gene causes a highly significant decrease in B-lymphopoiesis
and leads to the lack of bone marrow myelopoiesis.4
Experimental animals with impaired expression of SDF1
are found to have suffered perinatal mortality and ven-
tricular septal damage; thus, SDF1 is allegedly also involved
in directing progenitor cells to migrate to the appropriate
microenvironment to receive development and differenti-
ation signals. Physiologically, SDF1/CXCR4 signaling is also
involved in the migration of embryonic cells that partici-
pate in the development of the central nervous system,
bone marrow, and heart.4 Interaction of SDF1 and CXCR4
primarily affects chemotaxis; while the interaction of SDF1
and CXCR7, which is another receptor for SDF1, primarily
mediates proliferation of tumor cells.20
In addition to being expressed in the spleen and bone
marrow, SDF1 is also expressed in various cells in the liver,
lungs, kidneys, thymus, brain, stromal cells, cells of theimmune system, blood vessels, and heart.21,22 In addition to
lowering the number of SDF1-expressing cells in the spleen,
a sublethal dose of irradiation is found to decrease the
number of SDF1-expressing hepatocytes. As with the lym-
phocytes from the spleen and bone marrow, administration
of EMSA eritin was found to increase the number of SDF1-
expressing hepatocytes.
EMSA eritin used in this study was combined compounds
of the active components of polyherbal formulation of
brown rice, coconut milk, and soybeans. The use of these
compounds appeared to offer better results compared
with the administration of EPO currently often used in
patients receiving chemotherapy with irradiation. It
related with several bioactive compounds that have syn-
ergistic effects. Isoflavones of soybeans are found to be
candidate radioprotective agents against UV-B radiation
by eliminating the effects of free radicals and increasing
the activity of antioxidant enzymes.23 Flavonoids have
several biological functions, such as an anti-inflammation,
antioxidant, and antihuman immunodeficiency virus.
Additionally, it has cardio-protective properties, neuro-
protective properties, and anticarcinogenic properties.24
Genistein acts as an antioxidant and is found to interact
with estrogen receptors. It serves mainly as a tyrosine
kinase inhibitor, which is associated with a variety of
cellular growth and proliferation cascades.25 Genistein
can inhibit migration of human prostate cancer cells by
inhibiting promotility signaling, particularly by inhibiting
activation of focal adhesion kinase and p38 mitogen-
activated protein kinase-HSP27 signaling pathways.26
152 M. Ibrahim et al.Furthermore, genistein can inhibit SDF1-mediated
chemotaxis of CD4 T-cells.27 This is in contrast to the re-
sults of the present study that indicated that EMSA eritin,
one of the constituent components being genistein, could
increase SDF1-mediated migration of lymphocytes. In
addition, the antioxidants of pigmented rice are able to
scavenge free radicals due to radiation exposure.11 Co-
conut water contains cytokinins consisting of kinetin and
riboside12: these compounds are able to retard endothe-
lial cell senescence by increasing the capacity of cell
proliferation and cell metabolism.13 It was thought that
genistein had a different mechanism when administered
in normal conditions and after exposure to radiation; or, it
might be due to a difference in genistein functions when
acting alone and when combined with other active com-
pounds, including cytokinins and anthocyanins.
Recently, SDF1 has been found to be an important
component in the migration of lymphocytes to cross high
endothelial monolayers, representing a lymphoid struc-
ture.28 It is thought that during the migration of lym-
phocytes EMSA eritin continuously signals the cells to
express a high amount of SDF1 and prevent the cells from
insensitivity by blocking CXCR4 internalization after
continuous SDF1 stimulation. This is thought to be
important since downregulation of receptors will imme-
diately lead the cells’ response to be less sensitive to
chemokine ligands.29
In addition, results of the present study showed that
increased SDF1 expression due to administration of EMSA
eritin compounds could promote the pre-T cells to differ-
entiate and maturate immediately into both mature CD4
and CD8 T-cells. SDF1 has been found to increase self-
defense and proliferation of normal hematopoietic pro-
genitor cells and regulate B-cell development.30 The SDF1/
CXCR4 signaling pathway is thought to directly provide
important signals for hematopoietic cells’ proliferation and
differentiation. This is supported by a study indicating that
SDF1 is capable of stimulating in vitro proliferation of pre-B
cells.4 HSCs are found to interact with cells expressing SDF1
in high quantities.31 The SDF1/CXCR4 signaling pathway
plays an important role to prevent populations of hemato-
poietic stem cells from migration. SDF1 may activate
adhesion molecules, VLA-4 and LFA-1 in stem cells and
hematopoietic progenitor cells, which also act in the
homing of lymphocytes.32 Another study showed that mice
with damaged CXCR4 or SDF1 had abnormal migration of
granule cells. Restoring the number of SDF1-expressing
cells in irradiated mice treated with EMSA eritin is
thought to have positive effects on the negative effects of
irradiation; thus, the compound can be considered as a
candidate therapeutic agent to replace EPO.33
In conclusion, we reported that EMSA eritin, which is a
combined compound of polyherbal formulation of soy-
beans, brown rice, and coconut water, could be used as a
candidate therapeutic agent to replace EPO to induce
proliferation and differentiation of lymphocytes after
irradiation.Conflicts of interest
All authors declare no conflicts of interest.References
1. Shirozu M, Nakano T, Inazawa J, et al. Structure and chromo-
somal localization of the human stromal cell-derived factor 1
(SDF1) gene. Genomics. 1995;28:495e500.
2. Modi WS, Dean M, Seuanez HN, et al. Monocyte-derived
neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene
cluster along with several other members of the platelet factor
4 gene superfamily. Hum Genet. 1990;84:185e187.
3. Jiang W, Zhou P, Kahn SM, et al. Molecular cloning of TPAR1, a
gene whose expression is repressed by the tumor promoter 12-
otetradecanoylphorbor 13-acetate (TPA). Exp Cell Res. 1994;
215:284e293.
4. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell
lymphopoiesis and bonemarrow myelopoiesis in mice lacking
the CXC chemokine PBSF/SDF1. Nature. 1996;382:635e638.
5. Christopherson KW, Cooper S, Broxmeyer HE. Cell surface
peptidase CD26/DPPIV mediates G-CSF mobilization of mouse
progenitor cells. Blood. 2003;101:4680e4686.
6. Liles WC, Broxmeyer HE, Rodger E, et al. Mobilization of he-
matopoietic progenitor cells in healthy volunteers by AMD3100,
a CXCR4 antagonist. Blood. 2003;102:2728e2730.
7. Wang Y, Schulte BA, LaRue AC, et al. Total body irradiation
selectively induces murine hematopoietic stem cell senes-
cence. Blood. 2006;107:358e366.
8. Serrano M, Blasco M. Putting the stress on senescence. Curr
Opin Cell Biol. 2001;13:748e753.
9. Little JB. Radiation induced genomic instability. Int J Rad Biol.
1998;74:663e671.
10. Zhou YR, Kottmann AH, Kuroda M, et al. Function of the che-
mokine receptor CXCR4 in haematopoiesis and in cerebellar
development. Nature. 1998;393:595e599.
11. Escribano-Bailon MT, Santos-Buelga C, Rivas-Gonzalo JC. An-
thocyanins in cereals. J Chromatogr A. 2004;1054:129e141.
12. Ge L, Yong JWH, Goh NK, et al. Identification of kinetin and
kinetin riboside in coconut (Cocos nucifera L.) water using
a combined approach of liquid chromatography-tandem
mass spectrometry, high performance liquid chromatog-
raphy and capillary electrophoresis. J Chromatogr B. 2005;
829:26e34.
13. Liu Y, Zhang Z, Yang X. Kinetin protects against lipid peroxi-
dation and improves antioxidant status in cultured astrocytes
and mouse brain exposed to D-galactose. African J Biotechnol.
2011;10:11721e11727.
14. Peled A, Petit I, Kollet O, et al. Dependence of human stem
cell engraftment and repopulation of NOD/SCID mice on
CXCR4. Science. 1999;283:845e848.
15. Ratajczak MZ, Zuba-Surma E, Kucia M, et al. The plieotropic
effects of the SDF1-CXCR4 axis in organogenesis, regeneration
and tumorigenesis. Leukemia. 2006;20:1915e1924.
16. Garcia-Moruja C, Alonso-Lobo JM, Rueda P, et al. Functional
characterization of SDF1 proximal promoter. J Mol Biol. 2005;
348:43e62.
17. Ponomaryov T, Peled A, Petit I, et al. Induction of the che-
mokine stromal-derived factor-1 following DNA damage im-
proves human stem cell function. J Clin Invest. 2000;106:
1331e1339.
18. Fujimori A, Okayasu R, Ishihara H, et al. Extremely low dose
ionizing radiation up-regulates CXC chemokines in normal
human fibroblasts. Cancer Res. 2005;65:10159e10163.
19. Levesque JP, Hendy J, Takamatsu Y, et al. Disruption of the
CXCR4/CXCL12 chemotactic interaction during hematopoietic
stem cell mobilization induced by G-CSF or cyclophosphamide.
J Clin Invest. 2003;111:187e196.
20. Burns JM, Summers BC,WangY, et al. A novel chemokine receptor
for SDF1 and I-TAC involved in cell survival, cell adhesion, and
tumor development. J Exp Med. 2006;203:2201e2213.
Protective effects of polyherbal extracts 15321. Nervi B, Ramirez P, Rettig MP, et al. Chemosensitization of
acute myeloid leukemia (AML) following mobilization by the
CXCR4 antagonist AMD3100. Blood. 2009;113:6206e6214.
22. Jung Y, Wang J, Schneider A, et al. Regulation of SDF1 (CXCL12)
production by osteoblasts; a possible mechanism for stem cell
homing. Bone. 2006;38:497e508.
23. Zhang MW, Guo BJ, Zhang RF, et al. Separation, purification
and identification of antioxidant compositions in black rice.
Agr Sci China. 2006;5:431e440.
24. Kumari J. Health benefits of polyphenols and prevention of
disease in humans. IJPRBS. 2012;1:166e189.
25. Uckun FM, Messinger Y, Chen CL, et al. Treatment of therapy-
refractory B-lineage acute lymphoblastic leukemia with an
apoptosis-inducing CD19-directed tyrosine kinase inhibitor.
Clin Cancer Res. 1999;5:3906e3913.
26. Xu L, BerganRC.Genistein inhibitsmatrixmetalloproteinase type
2 activation and prostate cancer cell invasion by blocking the
transforming growth factor beta-mediated activation of mitoge-
nactivated protein kinase-activated protein kinase 2-27-kDa heat
shock protein pathway. Mol Pharmacol. 2006;70:869e877.
27. Shieh DB, Li RY, Liao JM, et al. Effects of genistein on beta-
catenin signaling and subcellular distribution of actin-binding
proteins in human umbilical CD105-positive stromal cells. J
Cell Physiol. 2010;223:423e434.28. Phillips R, Ager A. Activation of pertussis toxinsensitive CXCL12
(SDF1) receptors mediates transendothelial migration of T
lymphocytes across lymph node high endothelial cells. Eur J
Immunol. 2002;32:837e847.
29. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemo-
attractant SDF1 is a ligand for LESTR/fusin and blocks HIV-1
entry. Nature. 1996;382:829e833.
30. Broxmeyer HE, Kohli L, Kim CH, et al. Stromal cell-derived
factor-1/CXCL12 directly enhances survival/antiapoptosis of
myeloid progenitor cells through CXCR4 and G(alpha) proteins
and enhances engraftment of competitive, repopulating stem
cells. J Leukoc Biol. 2003;73:630e638.
31. Sugiyama T, Kohara H, Noda M, et al. Maintenance of the he-
matopoietic stem cell pool by CXCL12-CXCR4 chemokine
signaling in bone marrow stromal cell niches. Immunity. 2006;
25:977e988.
32. Peled A, Kollet O, Ponomaryov T, et al. The chemokine SDF1
activates the integrins LFA-1, VLA-4, and VLA-5 on immature
human CD34(þ) cells: role in transendothelial/stromal migra-
tion and engraftment of NOD/SCID mice. Blood. 2000;95:
3289e3296.
33. Altman J, Bayer SA. Development of the cerebellar system in
relation to its evolution, structure, and functions. Boca Raton:
FLL CRC Press; 1997.
